BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 9931911)

  • 41. Regional chemotherapy of nonresectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survival.
    Link KH; Sunelaitis E; Kornmann M; Schatz M; Gansauge F; Leder G; Formentini A; Staib L; Pillasch J; Beger HG
    Cancer; 2001 Dec; 92(11):2746-53. PubMed ID: 11753947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined therapy with radiofrequency thermal ablation and intra-arterial infusion chemotherapy for hepatic metastases from colorectal cancer.
    Kainuma O; Asano T; Aoyama H; Takayama W; Nakagohri T; Kenmochi T; Hasegawa M; Tokoro Y; Sasagawa S; Ochiai T
    Hepatogastroenterology; 1999; 46(26):1071-7. PubMed ID: 10370669
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer.
    ; Piedbois P; Buyse M; Kemeny N; Rougier P; Carlson R; Allen-Mersh T; O'Connell M; Chang A; Sondak V; Kemeny M; Levy E
    J Natl Cancer Inst; 1996 Mar; 88(5):252-8. PubMed ID: 8614003
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Concentration of 5-FU after hepatic artery infusion chemotherapy for liver metastases of colorectal cancer].
    Maruyama S; Ando M; Watayo T
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1635-8. PubMed ID: 14619482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin.
    Patt YZ; Hoque A; Lozano R; Pozdur R; Chase J; Carrasco H; Chuang V; Delpassand ES; Ellis L; Curley S; Roh M; Jones DV
    J Clin Oncol; 1997 Apr; 15(4):1432-8. PubMed ID: 9193336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver.
    O'Connell MJ; Nagorney DM; Bernath AM; Schroeder G; Fitzgibbons RJ; Mailliard JA; Burch P; Bolton JS; Colon-Otero G; Krook JE
    J Clin Oncol; 1998 Jul; 16(7):2528-33. PubMed ID: 9667274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intra-arterial infusion of 5-fluorouracil plus granulocyte-macrophage colony-stimulating factor (GM-CSF) and chemoembolization with melphalan in the treatment of disseminated colorectal liver metastases.
    Müller H; Nakchbandi W; Chatzissavvidis I; Valek V
    Eur J Surg Oncol; 2001 Nov; 27(7):652-61. PubMed ID: 11669594
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Preliminary clinical evaluation of low-dose cisplatin and continuous infusion of 5-FU (LFP) chemotherapy after weekly high-dose 5-FU therapy for the treatment of liver metastases from colorectal cancer].
    Itoh S; Morita S; Ohnishi T; Tsuji A; Takamatsu M; Horimi T
    Gan To Kagaku Ryoho; 2002 Jul; 29(7):1167-70. PubMed ID: 12145997
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hepatic arterial infusion chemotherapy for colorectal liver metastases].
    Kumada T; Sone Y; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kuzuya T; Nonogaki K; Shimizu J; Yamauti T; Kawase N
    Gan To Kagaku Ryoho; 2004 May; 31(5):700-5. PubMed ID: 15170976
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low-dose leucovorin and 5-Fluorouracil for unresectable multiple liver metastasis from colorectal cancer.
    Ishibashi K; Yoshimatsu K; Yokomizo H; Umehara A; Yoshida K; Fujimoto T; Watanabe K; Katsube T; Naritaka Y; Ogawa K
    Anticancer Res; 2005; 25(6C):4747-52. PubMed ID: 16334171
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatic arterial infusion (HAI) of cisplatin and systemic fluorouracil in the treatment of unresectable colorectal liver metastases.
    Mancini R; Tedesco M; Garufi C; Filippini A; Arcieri S; Caterino M; Pizzi G; Cortesi E; Spila A; Sperduti I; Cosimelli M
    Anticancer Res; 2003; 23(2C):1837-41. PubMed ID: 12820466
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alternating hepatic arterial infusion and systemic chemotherapy for liver metastases from colorectal cancer: a phase II trial using intermittent percutaneous hepatic arterial access.
    Copur MS; Capadano M; Lynch J; Goertzen T; McCowan T; Brand R; Tempero M
    J Clin Oncol; 2001 May; 19(9):2404-12. PubMed ID: 11331319
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Continuous hepatic arterial infusion of fluorouracil with leucovorin for liver metastases from colorectal cancer].
    Yamamura T; Matsuzaki H; Hashizume R; Arifuku T; Adachi Y; Nagaoka S; Kimura M; Akaishi O; Tsukikawa S
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1691-4. PubMed ID: 9382508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Two cases of multiple liver metastases from colorectal cancer which responded well to hepatic arterial infusion (HAI) using 5-fluorouracil and l-leucovorin].
    Kato S; Uetake H; Iida S; Higuchi T; Ishikawa T; Yasuno M; Enomoto M; Sugihara K
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1798-800. PubMed ID: 17212111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improved hepatic toxicity profile of portal vein adjuvant hepatic infusional chemotherapy.
    Faynsod M; Wagman LD; Longmate J; Carroll M; Leong LA
    J Clin Oncol; 2005 Aug; 23(22):4876-80. PubMed ID: 16009960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer.
    Kemeny N; Capanu M; D'Angelica M; Jarnagin W; Haviland D; Dematteo R; Fong Y
    Ann Oncol; 2009 Jul; 20(7):1236-41. PubMed ID: 19233901
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracil.
    Kerr DJ; Ledermann JA; McArdle CS; Buckels J; Neoptolemos J; Seymour M; Doughty J; Budden J; Taylor I
    J Clin Oncol; 1995 Dec; 13(12):2968-72. PubMed ID: 8523062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The efficacy and limitation of hepatic arterial infusion chemotherapy for colorectal liver metastases].
    Tono T; Ohzato H; Hasuike Y; Watanabe H; Hayashi S; Fukunaga M; Aihara T; Kan K; Imamoto H; Yamazaki K; Kikkawa N; Takatsuka Y
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1741-6. PubMed ID: 10560385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
    Aldrighetti L; Arru M; Ronzoni M; Salvioni M; Villa E; Ferla G
    Hepatogastroenterology; 2001; 48(41):1302-7. PubMed ID: 11677951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Repeated hepatic intra-arterial chemotherapy based on results of anticancer drug sensitivity test in patients with synchronous hepatic metastases from colorectal cancer.
    Matsuoka H; Nagaya M; Tsukikawa S; Yanagi Y; Isogai A; Kubota S
    Surgery; 2006 Sep; 140(3):387-95. PubMed ID: 16934600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.